

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.81597903 |
| 2 | definitive hemopoiesis (GO:0060216) | 5.86059259 |
| 3 | megakaryocyte development (GO:0035855) | 5.43796687 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.73922984 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.71256436 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.71256436 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 4.71256436 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.71256436 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.71256436 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.71256436 |
| 11 | response to peptidoglycan (GO:0032494) | 4.61136315 |
| 12 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.45118253 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.34090840 |
| 14 | positive regulation of B cell differentiation (GO:0045579) | 4.29073164 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.22379483 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.22379483 |
| 17 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.21939927 |
| 18 | viral transcription (GO:0019083) | 4.19485529 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.12012756 |
| 20 | detection of bacterium (GO:0016045) | 4.10670571 |
| 21 | negative regulation of cell killing (GO:0031342) | 4.08585554 |
| 22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.08585554 |
| 23 | response to interferon-beta (GO:0035456) | 4.07655621 |
| 24 | lymphoid progenitor cell differentiation (GO:0002320) | 4.04908892 |
| 25 | detection of other organism (GO:0098543) | 4.00492298 |
| 26 | platelet dense granule organization (GO:0060155) | 3.99306027 |
| 27 | response to muramyl dipeptide (GO:0032495) | 3.92711857 |
| 28 | embryonic hemopoiesis (GO:0035162) | 3.91302436 |
| 29 | mature B cell differentiation involved in immune response (GO:0002313) | 3.87691789 |
| 30 | translational termination (GO:0006415) | 3.85940670 |
| 31 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.78080790 |
| 32 | T cell homeostasis (GO:0043029) | 3.77940063 |
| 33 | regulation of erythrocyte differentiation (GO:0045646) | 3.74762419 |
| 34 | ribosomal small subunit biogenesis (GO:0042274) | 3.72202007 |
| 35 | mature B cell differentiation (GO:0002335) | 3.69278107 |
| 36 | regulation of granulocyte differentiation (GO:0030852) | 3.62336912 |
| 37 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.61530372 |
| 38 | positive thymic T cell selection (GO:0045059) | 3.60533645 |
| 39 | leukocyte aggregation (GO:0070486) | 3.60465544 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 3.59947928 |
| 41 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.59189852 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.59169236 |
| 43 | negative regulation of phagocytosis (GO:0050765) | 3.59144108 |
| 44 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.54211968 |
| 45 | response to host immune response (GO:0052572) | 3.52781645 |
| 46 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.52781645 |
| 47 | germinal center formation (GO:0002467) | 3.51487955 |
| 48 | regulation of B cell differentiation (GO:0045577) | 3.49929142 |
| 49 | lymph node development (GO:0048535) | 3.49848287 |
| 50 | cotranslational protein targeting to membrane (GO:0006613) | 3.46268600 |
| 51 | protein targeting to ER (GO:0045047) | 3.46120826 |
| 52 | regulation of leukocyte degranulation (GO:0043300) | 3.44876342 |
| 53 | positive regulation of mast cell activation (GO:0033005) | 3.40964777 |
| 54 | mast cell activation (GO:0045576) | 3.37987521 |
| 55 | endosome to melanosome transport (GO:0035646) | 3.37767990 |
| 56 | endosome to pigment granule transport (GO:0043485) | 3.37767990 |
| 57 | myeloid dendritic cell activation (GO:0001773) | 3.35241934 |
| 58 | defense response to protozoan (GO:0042832) | 3.31644060 |
| 59 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.30327855 |
| 60 | positive regulation of mast cell degranulation (GO:0043306) | 3.29734914 |
| 61 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.29734914 |
| 62 | regulation of mast cell activation (GO:0033003) | 3.29443755 |
| 63 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.29044278 |
| 64 | protein localization to endoplasmic reticulum (GO:0070972) | 3.28968457 |
| 65 | B cell mediated immunity (GO:0019724) | 3.27644317 |
| 66 | DNA deamination (GO:0045006) | 3.26038890 |
| 67 | translational elongation (GO:0006414) | 3.25448062 |
| 68 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.24554017 |
| 69 | negative thymic T cell selection (GO:0045060) | 3.23061820 |
| 70 | B cell receptor signaling pathway (GO:0050853) | 3.22540819 |
| 71 | secretory granule organization (GO:0033363) | 3.21409240 |
| 72 | response to type I interferon (GO:0034340) | 3.21294396 |
| 73 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.21284231 |
| 74 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.20282790 |
| 75 | cellular response to type I interferon (GO:0071357) | 3.18747289 |
| 76 | type I interferon signaling pathway (GO:0060337) | 3.18747289 |
| 77 | response to protozoan (GO:0001562) | 3.18084131 |
| 78 | negative regulation of T cell mediated immunity (GO:0002710) | 3.17610474 |
| 79 | response to host (GO:0075136) | 3.17489854 |
| 80 | response to host defenses (GO:0052200) | 3.17489854 |
| 81 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.17489854 |
| 82 | neutrophil activation (GO:0042119) | 3.16471809 |
| 83 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.15473430 |
| 84 | regulation of antigen processing and presentation (GO:0002577) | 3.14049597 |
| 85 | cellular response to interferon-beta (GO:0035458) | 3.13619630 |
| 86 | mast cell degranulation (GO:0043303) | 3.11805801 |
| 87 | mast cell activation involved in immune response (GO:0002279) | 3.11805801 |
| 88 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.09456917 |
| 89 | myeloid cell activation involved in immune response (GO:0002275) | 3.07789508 |
| 90 | regulation of regulated secretory pathway (GO:1903305) | 3.06791028 |
| 91 | thymic T cell selection (GO:0045061) | 3.05687514 |
| 92 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.04999713 |
| 93 | viral life cycle (GO:0019058) | 3.04899030 |
| 94 | T cell selection (GO:0045058) | 3.02870860 |
| 95 | * granulocyte differentiation (GO:0030851) | 3.01874398 |
| 96 | maturation of SSU-rRNA (GO:0030490) | 3.01115572 |
| 97 | Peyers patch development (GO:0048541) | 3.01088515 |
| 98 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.01088515 |
| 99 | detection of external biotic stimulus (GO:0098581) | 3.00589004 |
| 100 | cellular extravasation (GO:0045123) | 3.00021675 |
| 101 | negative T cell selection (GO:0043383) | 2.99183025 |
| 102 | respiratory burst (GO:0045730) | 2.98366147 |
| 103 | myeloid cell development (GO:0061515) | 2.98050938 |
| 104 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.97229800 |
| 105 | negative regulation of interleukin-12 production (GO:0032695) | 2.95622359 |
| 106 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.94682740 |
| 107 | myeloid dendritic cell differentiation (GO:0043011) | 2.93483933 |
| 108 | cellular protein complex disassembly (GO:0043624) | 2.93146182 |
| 109 | response to interleukin-15 (GO:0070672) | 2.92778241 |
| 110 | leukocyte degranulation (GO:0043299) | 2.92605115 |
| 111 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.91498959 |
| 112 | positive regulation of granulocyte differentiation (GO:0030854) | 2.91373209 |
| 113 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.90767675 |
| 114 | positive regulation of B cell activation (GO:0050871) | 2.89653161 |
| 115 | negative regulation of viral genome replication (GO:0045071) | 2.89109612 |
| 116 | response to interferon-alpha (GO:0035455) | 2.87828246 |
| 117 | energy homeostasis (GO:0097009) | 2.86859335 |
| 118 | immunoglobulin mediated immune response (GO:0016064) | 2.86720559 |
| 119 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.86442591 |
| 120 | positive regulation of antigen processing and presentation (GO:0002579) | 2.86292260 |
| 121 | leukocyte homeostasis (GO:0001776) | 2.85309366 |
| 122 | erythrocyte maturation (GO:0043249) | 2.83968408 |
| 123 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.83828792 |
| 124 | lymphocyte homeostasis (GO:0002260) | 2.83723284 |
| 125 | protein complex disassembly (GO:0043241) | 2.83684186 |
| 126 | positive regulation of respiratory burst (GO:0060267) | 2.83658139 |
| 127 | histone H3-K4 trimethylation (GO:0080182) | 2.83128596 |
| 128 | neutrophil activation involved in immune response (GO:0002283) | 2.80222421 |
| 129 | respiratory chain complex IV assembly (GO:0008535) | 2.79970796 |
| 130 | regulation of B cell apoptotic process (GO:0002902) | 2.79866996 |
| 131 | NIK/NF-kappaB signaling (GO:0038061) | 2.79435983 |
| 132 | natural killer cell differentiation (GO:0001779) | 2.79194558 |
| 133 | protein-DNA complex disassembly (GO:0032986) | 2.78858464 |
| 134 | nucleosome disassembly (GO:0006337) | 2.78858464 |
| 135 | execution phase of apoptosis (GO:0097194) | 2.78855099 |
| 136 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.78735783 |
| 137 | cellular response to exogenous dsRNA (GO:0071360) | 2.78612098 |
| 138 | granulocyte activation (GO:0036230) | 2.78606607 |
| 139 | positive T cell selection (GO:0043368) | 2.77047360 |
| 140 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.76968238 |
| 141 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.76230850 |
| 142 | regulation of gamma-delta T cell activation (GO:0046643) | 2.75592478 |
| 143 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.75250751 |
| 144 | B cell differentiation (GO:0030183) | 2.74707500 |
| 145 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.73322751 |
| 146 | positive regulation of regulated secretory pathway (GO:1903307) | 2.69213248 |
| 147 | histamine transport (GO:0051608) | 2.68977662 |
| 148 | positive regulation of Rap GTPase activity (GO:0032854) | 2.68932141 |
| 149 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.67040961 |
| 150 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.66793210 |
| 151 | erythrocyte differentiation (GO:0030218) | 2.66699206 |
| 152 | macromolecular complex disassembly (GO:0032984) | 2.66014568 |
| 153 | negative regulation of multicellular organism growth (GO:0040015) | 2.65287561 |
| 154 | T cell lineage commitment (GO:0002360) | 2.63582315 |
| 155 | regulation of mast cell degranulation (GO:0043304) | 2.61184128 |
| 156 | regulation of necroptotic process (GO:0060544) | 2.59415562 |
| 157 | dendritic cell differentiation (GO:0097028) | 2.56888092 |
| 158 | translational initiation (GO:0006413) | 2.54615893 |
| 159 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.53531228 |
| 160 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.53490087 |
| 161 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.53260054 |
| 162 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.52580041 |
| 163 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.50114697 |
| 164 | negative regulation of granulocyte differentiation (GO:0030853) | 2.49709628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 5.42359655 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.32282873 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.12186231 |
| 4 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.91410593 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.73316746 |
| 6 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.45598045 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.27917621 |
| 8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.11612026 |
| 9 | * MYC_22102868_ChIP-Seq_BL_Human | 3.10022655 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.09061522 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.06844548 |
| 12 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 3.05627354 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.87814969 |
| 14 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.87168812 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.85089137 |
| 16 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.69435100 |
| 17 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.65879572 |
| 18 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.48657280 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.45482538 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.40982293 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.40792607 |
| 22 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.40120211 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.39193986 |
| 24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.34411167 |
| 25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.27261786 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.19992185 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18792247 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.16909534 |
| 29 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.13102224 |
| 30 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.11429572 |
| 31 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.10984321 |
| 32 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.09312660 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.07476911 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.05997426 |
| 35 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04098856 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 2.02432729 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.02202201 |
| 38 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.00158836 |
| 39 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.96586657 |
| 40 | * MYB_26560356_Chip-Seq_TH2_Human | 1.93761678 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93395747 |
| 42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.88175735 |
| 43 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.87557257 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.84807061 |
| 45 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.84017338 |
| 46 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.82010462 |
| 47 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.80002276 |
| 48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79100123 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.77816541 |
| 50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.76468504 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.74449408 |
| 52 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.68471136 |
| 53 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.68402614 |
| 54 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.68387489 |
| 55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.63504056 |
| 56 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.62515753 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.57545658 |
| 58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.55672233 |
| 59 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.54352873 |
| 60 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49033319 |
| 61 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.48146437 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47111444 |
| 63 | P68_20966046_ChIP-Seq_HELA_Human | 1.45963341 |
| 64 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.40612014 |
| 65 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.35027057 |
| 66 | MAF_26560356_Chip-Seq_TH2_Human | 1.30958046 |
| 67 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.29875353 |
| 68 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.29426734 |
| 69 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26030524 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.25469876 |
| 71 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.23690669 |
| 72 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.21181472 |
| 73 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21159964 |
| 74 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21063617 |
| 75 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20319252 |
| 76 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.19756346 |
| 77 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.19074321 |
| 78 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.18719037 |
| 79 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18663507 |
| 80 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.16639650 |
| 81 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16401018 |
| 82 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15741405 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14805295 |
| 84 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14557339 |
| 85 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13973021 |
| 86 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.13178198 |
| 87 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.13107334 |
| 88 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.12239818 |
| 89 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.11321154 |
| 90 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10435198 |
| 91 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08551132 |
| 92 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.07845815 |
| 93 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07674487 |
| 94 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06939370 |
| 95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06859738 |
| 96 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.04729762 |
| 97 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.04040754 |
| 98 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.02956899 |
| 99 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.02440942 |
| 100 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.00654730 |
| 101 | P300_27268052_Chip-Seq_Bcells_Human | 1.00079407 |
| 102 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99561101 |
| 103 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.99324585 |
| 104 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99015852 |
| 105 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.98280858 |
| 106 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.98186728 |
| 107 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.97427517 |
| 108 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96549244 |
| 109 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96220392 |
| 110 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95376092 |
| 111 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95251880 |
| 112 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94734802 |
| 113 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93993062 |
| 114 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92853166 |
| 115 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91861455 |
| 116 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86492388 |
| 117 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.82780926 |
| 118 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.81768452 |
| 119 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.81411005 |
| 120 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81370589 |
| 121 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81062355 |
| 122 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.81058698 |
| 123 | GATA3_26560356_Chip-Seq_TH2_Human | 0.80201282 |
| 124 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79324099 |
| 125 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78937598 |
| 126 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.78838780 |
| 127 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78719408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.31934550 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.58901049 |
| 3 | MP0005174_abnormal_tail_pigmentation | 3.24744260 |
| 4 | MP0005671_abnormal_response_to | 2.80127531 |
| 5 | MP0004808_abnormal_hematopoietic_stem | 2.75476928 |
| 6 | MP0005397_hematopoietic_system_phenotyp | 2.67881095 |
| 7 | MP0001545_abnormal_hematopoietic_system | 2.67881095 |
| 8 | MP0000685_abnormal_immune_system | 2.66881202 |
| 9 | MP0009379_abnormal_foot_pigmentation | 2.51475437 |
| 10 | MP0004510_myositis | 2.46948096 |
| 11 | MP0006292_abnormal_olfactory_placode | 2.40850873 |
| 12 | MP0000465_gastrointestinal_hemorrhage | 2.39563513 |
| 13 | MP0005075_abnormal_melanosome_morpholog | 2.37757249 |
| 14 | MP0009785_altered_susceptibility_to | 2.36573098 |
| 15 | MP0004147_increased_porphyrin_level | 2.35789073 |
| 16 | MP0001800_abnormal_humoral_immune | 2.34264591 |
| 17 | MP0000015_abnormal_ear_pigmentation | 2.29324354 |
| 18 | * MP0002398_abnormal_bone_marrow | 2.28298086 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.23390500 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.22131238 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.19412884 |
| 22 | MP0005025_abnormal_response_to | 2.16195063 |
| 23 | MP0001819_abnormal_immune_cell | 2.15177288 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.14919076 |
| 25 | MP0002095_abnormal_skin_pigmentation | 2.13280914 |
| 26 | MP0005387_immune_system_phenotype | 2.12983689 |
| 27 | MP0001790_abnormal_immune_system | 2.12983689 |
| 28 | MP0002723_abnormal_immune_serum | 2.09148918 |
| 29 | MP0003763_abnormal_thymus_physiology | 2.07958318 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.94104998 |
| 31 | MP0000490_abnormal_crypts_of | 1.93030745 |
| 32 | * MP0000716_abnormal_immune_system | 1.91816964 |
| 33 | MP0009278_abnormal_bone_marrow | 1.87864555 |
| 34 | MP0002419_abnormal_innate_immunity | 1.87475950 |
| 35 | MP0002166_altered_tumor_susceptibility | 1.87394022 |
| 36 | MP0003303_peritoneal_inflammation | 1.86625078 |
| 37 | MP0001873_stomach_inflammation | 1.86085272 |
| 38 | MP0003724_increased_susceptibility_to | 1.84405181 |
| 39 | MP0005451_abnormal_body_composition | 1.80899501 |
| 40 | * MP0000689_abnormal_spleen_morphology | 1.73792373 |
| 41 | * MP0002429_abnormal_blood_cell | 1.71568494 |
| 42 | * MP0002722_abnormal_immune_system | 1.68214347 |
| 43 | MP0003436_decreased_susceptibility_to | 1.65501016 |
| 44 | MP0005409_darkened_coat_color | 1.59956947 |
| 45 | MP0001986_abnormal_taste_sensitivity | 1.58271855 |
| 46 | MP0001188_hyperpigmentation | 1.53402978 |
| 47 | MP0002877_abnormal_melanocyte_morpholog | 1.52661777 |
| 48 | MP0006054_spinal_hemorrhage | 1.50824038 |
| 49 | MP0000703_abnormal_thymus_morphology | 1.47805133 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.47527235 |
| 51 | MP0003866_abnormal_defecation | 1.46714944 |
| 52 | MP0001853_heart_inflammation | 1.42226388 |
| 53 | MP0008260_abnormal_autophagy | 1.41854781 |
| 54 | MP0003693_abnormal_embryo_hatching | 1.38897162 |
| 55 | MP0005310_abnormal_salivary_gland | 1.37532410 |
| 56 | MP0001879_abnormal_lymphatic_vessel | 1.34421009 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 1.33843383 |
| 58 | MP0008995_early_reproductive_senescence | 1.32960193 |
| 59 | MP0002405_respiratory_system_inflammati | 1.32395524 |
| 60 | MP0004381_abnormal_hair_follicle | 1.31105898 |
| 61 | MP0010368_abnormal_lymphatic_system | 1.28477010 |
| 62 | MP0004947_skin_inflammation | 1.28121638 |
| 63 | MP0003191_abnormal_cellular_cholesterol | 1.27697993 |
| 64 | MP0003787_abnormal_imprinting | 1.25738333 |
| 65 | MP0002006_tumorigenesis | 1.25264922 |
| 66 | MP0003943_abnormal_hepatobiliary_system | 1.24954619 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.16241089 |
| 68 | MP0003828_pulmonary_edema | 1.15658047 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 1.13668013 |
| 70 | MP0010094_abnormal_chromosome_stability | 1.07380573 |
| 71 | MP0002638_abnormal_pupillary_reflex | 1.05943329 |
| 72 | MP0005083_abnormal_biliary_tract | 1.05239804 |
| 73 | MP0000681_abnormal_thyroid_gland | 1.01902174 |
| 74 | MP0002693_abnormal_pancreas_physiology | 1.01268734 |
| 75 | MP0000569_abnormal_digit_pigmentation | 1.01055118 |
| 76 | MP0008058_abnormal_DNA_repair | 0.99896059 |
| 77 | MP0001663_abnormal_digestive_system | 0.98598905 |
| 78 | MP0008007_abnormal_cellular_replicative | 0.96480903 |
| 79 | MP0009764_decreased_sensitivity_to | 0.95625065 |
| 80 | MP0002876_abnormal_thyroid_physiology | 0.91872802 |
| 81 | MP0008469_abnormal_protein_level | 0.91340552 |
| 82 | MP0003183_abnormal_peptide_metabolism | 0.91186405 |
| 83 | MP0005058_abnormal_lysosome_morphology | 0.89067814 |
| 84 | MP0003806_abnormal_nucleotide_metabolis | 0.87687288 |
| 85 | MP0006082_CNS_inflammation | 0.86228129 |
| 86 | MP0002822_catalepsy | 0.85772538 |
| 87 | MP0005379_endocrine/exocrine_gland_phen | 0.84017423 |
| 88 | MP0000313_abnormal_cell_death | 0.83258782 |
| 89 | MP0006036_abnormal_mitochondrial_physio | 0.82741646 |
| 90 | MP0002132_abnormal_respiratory_system | 0.82622587 |
| 91 | MP0005535_abnormal_body_temperature | 0.82597740 |
| 92 | MP0005645_abnormal_hypothalamus_physiol | 0.82242792 |
| 93 | MP0001851_eye_inflammation | 0.80073823 |
| 94 | MP0003300_gastrointestinal_ulcer | 0.79529955 |
| 95 | MP0008057_abnormal_DNA_replication | 0.78773400 |
| 96 | MP0001944_abnormal_pancreas_morphology | 0.78684159 |
| 97 | MP0002019_abnormal_tumor_incidence | 0.78285501 |
| 98 | MP0005220_abnormal_exocrine_pancreas | 0.78038257 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 0.75736541 |
| 100 | MP0008874_decreased_physiological_sensi | 0.75215938 |
| 101 | MP0005084_abnormal_gallbladder_morpholo | 0.74028050 |
| 102 | MP0002163_abnormal_gland_morphology | 0.73059260 |
| 103 | MP0008004_abnormal_stomach_pH | 0.72326805 |
| 104 | MP0003077_abnormal_cell_cycle | 0.72260603 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 0.70239603 |
| 106 | MP0005076_abnormal_cell_differentiation | 0.69934086 |
| 107 | MP0000678_abnormal_parathyroid_gland | 0.69489456 |
| 108 | MP0000372_irregular_coat_pigmentation | 0.69278367 |
| 109 | MP0002009_preneoplasia | 0.67560969 |
| 110 | MP0003075_altered_response_to | 0.67118076 |
| 111 | MP0000371_diluted_coat_color | 0.65312705 |
| 112 | MP0003172_abnormal_lysosome_physiology | 0.64972338 |
| 113 | MP0003646_muscle_fatigue | 0.64451252 |
| 114 | MP0009763_increased_sensitivity_to | 0.62997681 |
| 115 | MP0003111_abnormal_nucleus_morphology | 0.61815844 |
| 116 | MP0009931_abnormal_skin_appearance | 0.61618989 |
| 117 | MP0000858_altered_metastatic_potential | 0.61524404 |
| 118 | MP0003868_abnormal_feces_composition | 0.61298723 |
| 119 | MP0001502_abnormal_circadian_rhythm | 0.59630370 |
| 120 | MP0002075_abnormal_coat/hair_pigmentati | 0.58972701 |
| 121 | MP0004185_abnormal_adipocyte_glucose | 0.57959257 |
| 122 | MP0008961_abnormal_basal_metabolism | 0.57729029 |
| 123 | MP0005666_abnormal_adipose_tissue | 0.57587423 |
| 124 | MP0002653_abnormal_ependyma_morphology | 0.54489122 |
| 125 | MP0002933_joint_inflammation | 0.54411083 |
| 126 | MP0005334_abnormal_fat_pad | 0.53804077 |
| 127 | MP0001533_abnormal_skeleton_physiology | 0.53372352 |
| 128 | MP0009115_abnormal_fat_cell | 0.52357983 |
| 129 | MP0002083_premature_death | 0.49837399 |
| 130 | MP0005166_decreased_susceptibility_to | 0.49467312 |
| 131 | MP0000609_abnormal_liver_physiology | 0.49244056 |
| 132 | MP0004145_abnormal_muscle_electrophysio | 0.47702580 |
| 133 | MP0005381_digestive/alimentary_phenotyp | 0.46807792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 5.75681482 |
| 2 | Thrombocytosis (HP:0001894) | 4.98679528 |
| 3 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.60388384 |
| 4 | Petechiae (HP:0000967) | 4.53906890 |
| 5 | Prolonged bleeding time (HP:0003010) | 4.42271615 |
| 6 | Agammaglobulinemia (HP:0004432) | 4.26523845 |
| 7 | Aplastic anemia (HP:0001915) | 4.16660658 |
| 8 | Panhypogammaglobulinemia (HP:0003139) | 4.10396166 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.82158937 |
| 10 | IgM deficiency (HP:0002850) | 3.62075161 |
| 11 | Increased IgE level (HP:0003212) | 3.61372592 |
| 12 | Abnormal number of erythroid precursors (HP:0012131) | 3.58901068 |
| 13 | Stomatitis (HP:0010280) | 3.56646717 |
| 14 | Reticulocytopenia (HP:0001896) | 3.50389024 |
| 15 | Recurrent viral infections (HP:0004429) | 3.47126980 |
| 16 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.43115304 |
| 17 | Cellulitis (HP:0100658) | 3.39359767 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.38277804 |
| 19 | Recurrent abscess formation (HP:0002722) | 3.36771277 |
| 20 | Cerebral palsy (HP:0100021) | 3.24828558 |
| 21 | Orchitis (HP:0100796) | 3.22355453 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.22354772 |
| 23 | Chronic otitis media (HP:0000389) | 3.16014112 |
| 24 | Hypertensive crisis (HP:0100735) | 3.15899100 |
| 25 | Meningitis (HP:0001287) | 3.14647090 |
| 26 | Epistaxis (HP:0000421) | 3.12363668 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.11969924 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.11969924 |
| 29 | Recurrent fungal infections (HP:0002841) | 3.10283077 |
| 30 | Urticaria (HP:0001025) | 3.04165909 |
| 31 | Inflammation of the large intestine (HP:0002037) | 3.03588655 |
| 32 | Gastrointestinal inflammation (HP:0004386) | 3.01890200 |
| 33 | Colitis (HP:0002583) | 3.00577088 |
| 34 | Abnormal platelet function (HP:0011869) | 2.99847901 |
| 35 | Impaired platelet aggregation (HP:0003540) | 2.99847901 |
| 36 | Abnormality of the fingertips (HP:0001211) | 2.99840285 |
| 37 | Gastrointestinal stroma tumor (HP:0100723) | 2.96962266 |
| 38 | Spontaneous hematomas (HP:0007420) | 2.93002000 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 2.90383797 |
| 40 | Optic neuritis (HP:0100653) | 2.90383797 |
| 41 | Acute lymphatic leukemia (HP:0006721) | 2.88375274 |
| 42 | Abnormality of T cell physiology (HP:0011840) | 2.84565030 |
| 43 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.80940183 |
| 44 | Osteomyelitis (HP:0002754) | 2.76978893 |
| 45 | Gastrointestinal infarctions (HP:0005244) | 2.75662497 |
| 46 | Granulocytopenia (HP:0001913) | 2.75620597 |
| 47 | Hypochromic anemia (HP:0001931) | 2.71734343 |
| 48 | Type 2 muscle fiber atrophy (HP:0003554) | 2.68813481 |
| 49 | Type I transferrin isoform profile (HP:0003642) | 2.65336170 |
| 50 | Spinal cord lesions (HP:0100561) | 2.64595656 |
| 51 | Syringomyelia (HP:0003396) | 2.64595656 |
| 52 | Broad face (HP:0000283) | 2.59797480 |
| 53 | Tented upper lip vermilion (HP:0010804) | 2.59580989 |
| 54 | Hypochromic microcytic anemia (HP:0004840) | 2.59168194 |
| 55 | Recurrent skin infections (HP:0001581) | 2.57883041 |
| 56 | Sepsis (HP:0100806) | 2.57081718 |
| 57 | Large eyes (HP:0001090) | 2.55558590 |
| 58 | Myositis (HP:0100614) | 2.55543946 |
| 59 | Reduced antithrombin III activity (HP:0001976) | 2.54383267 |
| 60 | Muscle fiber atrophy (HP:0100295) | 2.52235684 |
| 61 | Reticulocytosis (HP:0001923) | 2.50354570 |
| 62 | Pallor (HP:0000980) | 2.49798188 |
| 63 | Myelodysplasia (HP:0002863) | 2.49148489 |
| 64 | B lymphocytopenia (HP:0010976) | 2.47951108 |
| 65 | Abnormality of B cell number (HP:0010975) | 2.47951108 |
| 66 | Recurrent bronchitis (HP:0002837) | 2.47438534 |
| 67 | Papilloma (HP:0012740) | 2.44767644 |
| 68 | Verrucae (HP:0200043) | 2.44767644 |
| 69 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.43812618 |
| 70 | Abnormal platelet volume (HP:0011876) | 2.41308489 |
| 71 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.38782476 |
| 72 | Leukocytosis (HP:0001974) | 2.38427609 |
| 73 | Acute myeloid leukemia (HP:0004808) | 2.38423933 |
| 74 | Episodic fever (HP:0001954) | 2.37712485 |
| 75 | Recurrent sinusitis (HP:0011108) | 2.34846866 |
| 76 | Hyperthyroidism (HP:0000836) | 2.32511452 |
| 77 | Gingivitis (HP:0000230) | 2.32472223 |
| 78 | Thyroiditis (HP:0100646) | 2.32197429 |
| 79 | Abnormality of the nasal mucosa (HP:0000433) | 2.31747016 |
| 80 | Increased serum ferritin (HP:0003281) | 2.30143938 |
| 81 | Chest pain (HP:0100749) | 2.29137088 |
| 82 | Keratoconjunctivitis sicca (HP:0001097) | 2.26448695 |
| 83 | Increased IgM level (HP:0003496) | 2.25059559 |
| 84 | Seborrheic dermatitis (HP:0001051) | 2.24758044 |
| 85 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.23776736 |
| 86 | Neutropenia (HP:0001875) | 2.23657972 |
| 87 | Abnormality of iron homeostasis (HP:0011031) | 2.23251175 |
| 88 | Microcytic anemia (HP:0001935) | 2.23079572 |
| 89 | Skin rash (HP:0000988) | 2.22971892 |
| 90 | Encephalitis (HP:0002383) | 2.20803756 |
| 91 | Abnormality of T cells (HP:0002843) | 2.20731125 |
| 92 | Fatigue (HP:0012378) | 2.20723209 |
| 93 | Abnormality of DNA repair (HP:0003254) | 2.19269757 |
| 94 | Pulmonary fibrosis (HP:0002206) | 2.18162607 |
| 95 | Optic nerve coloboma (HP:0000588) | 2.17284083 |
| 96 | Hyperacusis (HP:0010780) | 2.16224818 |
| 97 | Gingival bleeding (HP:0000225) | 2.07835612 |
| 98 | Polycythemia (HP:0001901) | 2.07589446 |
| 99 | Obstructive lung disease (HP:0006536) | 2.07492986 |
| 100 | Chronic obstructive pulmonary disease (HP:0006510) | 2.07492986 |
| 101 | Viral hepatitis (HP:0006562) | 2.05571473 |
| 102 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.05551498 |
| 103 | Exertional dyspnea (HP:0002875) | 2.04096134 |
| 104 | Albinism (HP:0001022) | 2.04028400 |
| 105 | Hypergammaglobulinemia (HP:0010702) | 2.03470167 |
| 106 | Amaurosis fugax (HP:0100576) | 2.03442638 |
| 107 | Hemoptysis (HP:0002105) | 2.03177226 |
| 108 | Purpura (HP:0000979) | 2.03032682 |
| 109 | Chromsome breakage (HP:0040012) | 2.02895352 |
| 110 | Clubbing of toes (HP:0100760) | 2.02845905 |
| 111 | Mediastinal lymphadenopathy (HP:0100721) | 2.02394991 |
| 112 | Hypoproteinemia (HP:0003075) | 2.02206952 |
| 113 | Pulmonary embolism (HP:0002204) | 2.01648172 |
| 114 | Pulmonary infiltrates (HP:0002113) | 2.01397740 |
| 115 | Skin ulcer (HP:0200042) | 1.99669490 |
| 116 | 11 pairs of ribs (HP:0000878) | 1.99181852 |
| 117 | Keratoconjunctivitis (HP:0001096) | 1.99072101 |
| 118 | Nasal polyposis (HP:0100582) | 1.95118692 |
| 119 | Abnormality of the pleura (HP:0002103) | 1.93001261 |
| 120 | Abnormality of the columella (HP:0009929) | 1.92997591 |
| 121 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.92557347 |
| 122 | Autoimmune hemolytic anemia (HP:0001890) | 1.92386018 |
| 123 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.92031635 |
| 124 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.92031635 |
| 125 | Abnormal protein glycosylation (HP:0012346) | 1.92031635 |
| 126 | Abnormal glycosylation (HP:0012345) | 1.92031635 |
| 127 | Hepatosplenomegaly (HP:0001433) | 1.91863613 |
| 128 | Vasculitis (HP:0002633) | 1.91845617 |
| 129 | Vertigo (HP:0002321) | 1.91584740 |
| 130 | Menorrhagia (HP:0000132) | 1.90317077 |
| 131 | Lymphopenia (HP:0001888) | 1.90048174 |
| 132 | Truncus arteriosus (HP:0001660) | 1.90032920 |
| 133 | Abnormality of the thoracic spine (HP:0100711) | 1.89284597 |
| 134 | Abnormal gallbladder physiology (HP:0012438) | 1.89048774 |
| 135 | Cholecystitis (HP:0001082) | 1.89048774 |
| 136 | Volvulus (HP:0002580) | 1.88674839 |
| 137 | Arterial thrombosis (HP:0004420) | 1.88575580 |
| 138 | Slow saccadic eye movements (HP:0000514) | 1.88270204 |
| 139 | Visual hallucinations (HP:0002367) | 1.86529654 |
| 140 | Eczematoid dermatitis (HP:0000976) | 1.85303488 |
| 141 | Abnormality of the prostate (HP:0008775) | 1.84665092 |
| 142 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.82632371 |
| 143 | Hypothermia (HP:0002045) | 1.82513734 |
| 144 | Easy fatigability (HP:0003388) | 1.81117212 |
| 145 | IgG deficiency (HP:0004315) | 1.79785674 |
| 146 | Recurrent lower respiratory tract infections (HP:0002783) | 1.76537726 |
| 147 | Lymphoma (HP:0002665) | 1.76042799 |
| 148 | Synophrys (HP:0000664) | 1.73512872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KIT | 3.50488258 |
| 2 | ERN1 | 3.43445191 |
| 3 | MAP4K1 | 3.20297193 |
| 4 | IRAK4 | 2.86962294 |
| 5 | TAOK3 | 2.84631929 |
| 6 | TIE1 | 2.31329693 |
| 7 | TNIK | 2.13993206 |
| 8 | TRIB3 | 2.09545997 |
| 9 | GRK6 | 2.06697268 |
| 10 | BTK | 2.02944342 |
| 11 | JAK3 | 1.99738016 |
| 12 | MUSK | 1.98928034 |
| 13 | FES | 1.86853368 |
| 14 | TGFBR1 | 1.83910622 |
| 15 | MAP2K7 | 1.78098721 |
| 16 | EEF2K | 1.77322968 |
| 17 | MAP3K11 | 1.76987259 |
| 18 | SYK | 1.74158272 |
| 19 | TEC | 1.72262853 |
| 20 | FLT3 | 1.71473791 |
| 21 | CSF1R | 1.69918418 |
| 22 | TBK1 | 1.64343480 |
| 23 | TYK2 | 1.58926234 |
| 24 | MAP3K14 | 1.55404332 |
| 25 | SIK2 | 1.54742300 |
| 26 | STK16 | 1.53024854 |
| 27 | BLK | 1.52225642 |
| 28 | TGFBR2 | 1.46181574 |
| 29 | MKNK2 | 1.45255940 |
| 30 | SCYL2 | 1.45189689 |
| 31 | MATK | 1.44070957 |
| 32 | IKBKE | 1.43803513 |
| 33 | MAP3K6 | 1.42701311 |
| 34 | TESK2 | 1.41905849 |
| 35 | PIM2 | 1.41463802 |
| 36 | RIPK4 | 1.38712962 |
| 37 | MAP3K1 | 1.34966428 |
| 38 | SMG1 | 1.34470678 |
| 39 | IKBKB | 1.32288289 |
| 40 | PIM1 | 1.32252468 |
| 41 | NME2 | 1.30063893 |
| 42 | SRPK1 | 1.28470613 |
| 43 | ZAP70 | 1.28177792 |
| 44 | MARK2 | 1.26498521 |
| 45 | TNK2 | 1.25384803 |
| 46 | DYRK3 | 1.23952623 |
| 47 | IRAK3 | 1.20385951 |
| 48 | MAP2K3 | 1.18677322 |
| 49 | MAP3K12 | 1.17047634 |
| 50 | MAPK12 | 1.16213668 |
| 51 | SIK3 | 1.15319127 |
| 52 | CHUK | 1.14984226 |
| 53 | CDK12 | 1.14309871 |
| 54 | TAOK1 | 1.13869049 |
| 55 | CDK19 | 1.13816835 |
| 56 | VRK1 | 1.06916630 |
| 57 | CDK8 | 1.06084290 |
| 58 | MKNK1 | 1.05643578 |
| 59 | KDR | 0.96978954 |
| 60 | BRD4 | 0.95556828 |
| 61 | LRRK2 | 0.93678156 |
| 62 | PRKD2 | 0.93129794 |
| 63 | HIPK2 | 0.91797283 |
| 64 | LYN | 0.91707536 |
| 65 | CLK1 | 0.91621975 |
| 66 | MAP2K2 | 0.91536512 |
| 67 | TXK | 0.89976999 |
| 68 | MAP3K10 | 0.89120450 |
| 69 | RPS6KA6 | 0.86221622 |
| 70 | PDK1 | 0.86029359 |
| 71 | MARK3 | 0.85830388 |
| 72 | SIK1 | 0.84642756 |
| 73 | ITK | 0.84002224 |
| 74 | RPS6KB2 | 0.81516494 |
| 75 | CAMK1 | 0.81110510 |
| 76 | PKN2 | 0.79458103 |
| 77 | KSR2 | 0.75600064 |
| 78 | YES1 | 0.74686467 |
| 79 | RPS6KL1 | 0.72920593 |
| 80 | RPS6KC1 | 0.72920593 |
| 81 | MAPK4 | 0.72207334 |
| 82 | PDPK1 | 0.70897867 |
| 83 | RPS6KA2 | 0.69412593 |
| 84 | CDK4 | 0.68946458 |
| 85 | LCK | 0.67819144 |
| 86 | HCK | 0.67506061 |
| 87 | MAP2K6 | 0.67231409 |
| 88 | TAOK2 | 0.66159182 |
| 89 | PRKCQ | 0.64855864 |
| 90 | DAPK1 | 0.63245169 |
| 91 | ATR | 0.62830495 |
| 92 | BCKDK | 0.62673259 |
| 93 | RAF1 | 0.62480924 |
| 94 | NLK | 0.61537983 |
| 95 | MYLK | 0.61235689 |
| 96 | ACVR1B | 0.60853241 |
| 97 | PASK | 0.59427702 |
| 98 | CCNB1 | 0.59109968 |
| 99 | MAP2K4 | 0.58947093 |
| 100 | IRAK2 | 0.58414848 |
| 101 | MAPK13 | 0.56781931 |
| 102 | CDK9 | 0.54808614 |
| 103 | MAPKAPK5 | 0.53611112 |
| 104 | MAP3K7 | 0.53289666 |
| 105 | DAPK2 | 0.52533982 |
| 106 | MAPK7 | 0.51303821 |
| 107 | CAMKK1 | 0.50364094 |
| 108 | MAP3K3 | 0.49548544 |
| 109 | SGK2 | 0.49402772 |
| 110 | RET | 0.49147730 |
| 111 | MAP3K13 | 0.48000132 |
| 112 | MAPK3 | 0.47405864 |
| 113 | STK10 | 0.47240849 |
| 114 | JAK1 | 0.46663907 |
| 115 | PTK6 | 0.46174098 |
| 116 | CDC42BPA | 0.45876886 |
| 117 | CAMKK2 | 0.44869827 |
| 118 | FYN | 0.44544883 |
| 119 | EPHB1 | 0.44517088 |
| 120 | RPS6KA4 | 0.44030758 |
| 121 | FGFR3 | 0.43986861 |
| 122 | JAK2 | 0.43286485 |
| 123 | CDK7 | 0.43199707 |
| 124 | MAPK11 | 0.42756342 |
| 125 | ICK | 0.42191761 |
| 126 | FGR | 0.41897555 |
| 127 | ZAK | 0.41630474 |
| 128 | BMPR1B | 0.40322641 |
| 129 | RPS6KA5 | 0.39973071 |
| 130 | BMPR2 | 0.39524365 |
| 131 | BRSK2 | 0.39512296 |
| 132 | IRAK1 | 0.39333373 |
| 133 | DYRK1B | 0.39280055 |
| 134 | RPS6KB1 | 0.38555722 |
| 135 | STK4 | 0.37736557 |
| 136 | ALK | 0.37197424 |
| 137 | PRPF4B | 0.36861825 |
| 138 | CSK | 0.35502791 |
| 139 | PRKD1 | 0.34347734 |
| 140 | PIK3CG | 0.33233316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.31483605 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.56284197 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.52287259 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.28978718 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.26133238 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.07727302 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.05344444 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.01614895 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.80220640 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.74348059 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 1.72679701 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.69428474 |
| 13 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.68074123 |
| 14 | Mismatch repair_Homo sapiens_hsa03430 | 1.59659009 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.58588781 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.57772455 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.57441577 |
| 18 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.56105860 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.55916183 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.54271568 |
| 21 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.53472623 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53126633 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.50937446 |
| 24 | Spliceosome_Homo sapiens_hsa03040 | 1.49133223 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.47076435 |
| 26 | Platelet activation_Homo sapiens_hsa04611 | 1.44023958 |
| 27 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.40277814 |
| 28 | Homologous recombination_Homo sapiens_hsa03440 | 1.36234708 |
| 29 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.30961002 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.28260420 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26943106 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.26705176 |
| 33 | RNA degradation_Homo sapiens_hsa03018 | 1.23569123 |
| 34 | Protein export_Homo sapiens_hsa03060 | 1.20794943 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.18189033 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.16145982 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.15507687 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.14049720 |
| 39 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.13958507 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.13187259 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12701942 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.10855135 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07846821 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06033914 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.04746387 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 1.04527436 |
| 47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.01828748 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.01621964 |
| 49 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.99645919 |
| 50 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.99325630 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.97399969 |
| 52 | Allograft rejection_Homo sapiens_hsa05330 | 0.96261334 |
| 53 | Tuberculosis_Homo sapiens_hsa05152 | 0.94974210 |
| 54 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.94051704 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92869367 |
| 56 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92026332 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90905736 |
| 58 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.89616864 |
| 59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87783938 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86750578 |
| 61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85803310 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85179500 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85070067 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84256651 |
| 65 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84034224 |
| 66 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.84002374 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 0.81595221 |
| 68 | Cell cycle_Homo sapiens_hsa04110 | 0.78970880 |
| 69 | Asthma_Homo sapiens_hsa05310 | 0.77006894 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75706836 |
| 71 | RNA polymerase_Homo sapiens_hsa03020 | 0.72920432 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72220864 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71713092 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71490885 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.70084904 |
| 76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69155148 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68594028 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65123028 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62974490 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62329758 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62243525 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.61088228 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61079467 |
| 84 | Purine metabolism_Homo sapiens_hsa00230 | 0.60750621 |
| 85 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.60710559 |
| 86 | Salmonella infection_Homo sapiens_hsa05132 | 0.60537633 |
| 87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59116033 |
| 88 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.58527196 |
| 89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57488525 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56564714 |
| 91 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55013798 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54295593 |
| 93 | Malaria_Homo sapiens_hsa05144 | 0.54224864 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54151914 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53981877 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53569726 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53167088 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53103534 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52953331 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52413218 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51408083 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50344418 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.50144723 |
| 104 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49763527 |
| 105 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49553801 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49363715 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.47759569 |
| 108 | Legionellosis_Homo sapiens_hsa05134 | 0.47300322 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46941772 |
| 110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45756680 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45740198 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | 0.45346362 |
| 113 | Circadian entrainment_Homo sapiens_hsa04713 | 0.44908985 |
| 114 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.44633909 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43639791 |
| 116 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43280472 |
| 117 | Basal transcription factors_Homo sapiens_hsa03022 | 0.42309962 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41435659 |
| 119 | Alcoholism_Homo sapiens_hsa05034 | 0.41349233 |
| 120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41120982 |
| 121 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.39631207 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.39570018 |
| 123 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39562144 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39398722 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39349825 |
| 126 | Glioma_Homo sapiens_hsa05214 | 0.39147203 |
| 127 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37653576 |
| 128 | Morphine addiction_Homo sapiens_hsa05032 | 0.37633527 |
| 129 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37151157 |
| 130 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35779649 |
| 131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34259970 |
| 132 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.34256771 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34083430 |
| 134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32472760 |
| 135 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31304977 |

